| 美機構正式起訴中共製造生武索賠$20萬億美元以上 |
| 送交者: Pascal 2020年03月21日20:07:04 於 [五 味 齋] 發送悄悄話 |
|
原告:
A former federal prosecutor, Larry Klayman ( 1951- ) founded conservative legal group Judicial Watch and Freedom Watch. 被告:
事由:
I. INTRODUCTION AND NATURE OF THE ACTION 1. This is a complaint for damages and equitable relief arising out of the creation andrelease, accidental or otherwise, of a variation of coronavirus known as COVID-19 by the People's Republic of China and its agencies and officials as a biological weapon in violation of China's agreements under international treaties, and recklessly or otherwise allowing its release from the Wuhan Institute of Virology into the city of Wuhan, China, in Hubei Province, by among other acts failing to prevent the Institute's personnel from becoming infected with the bioweapon and carrying it into the surrounding community and proliferation into the United States. 2. Since biological weapons have been outlawed since at least 1925, including by China's membership in treaties, these illegal weapons constitute and are in effect terrorist- related weapons of mass destruction of population centers. 3. This is a civil action on behalf of the lead Plaintiffs and other members of the class comprised of subclasses identified herein of those directly injured by the spread of COVID-19. 媒體報道新型冠狀病毒第一位患者:
中共設計甚為有效、具有災難性質 大規模滅絕人口生物戰武器:
儘管:
索賠:
https://www.freedomwatchusa.org/pdf/200317-CoronavirusFILEDComplaint177113137478.pdf
https://www.freedomwatchusa.org/freedom-watch-and-klayman-file-class-action-suit-vs-china-ov
https://www.freedomwatchusa.org/chicoms-must-pay-for-impact-of-covid-19
|
|
![]() | |
|
![]() |
| 實用資訊 | |
|
|
| 一周點擊熱帖 | 更多>> |
| 一周回復熱帖 |
| 歷史上的今天:回復熱帖 |
| 2019: | 附加題: 無理數的無窮, 數域的擴展, | |
| 2019: | 老k又在抵毀疫苗了。傳統百白破疫苗腦 | |
| 2018: | 中共說美國敢實施台灣旅遊法就將全面性 | |
| 2018: | 上海強製取消綠卡持有者的戶籍,隔壁茶 | |
| 2017: | 西方左派是斯大林毛賊東lite | |
| 2017: | 後大選時代,論華人不團結的根源 | |
| 2016: | cnoversea,再向你請教一個發音問題 | |
| 2016: | 流利的上海話英語 | |
| 2015: | 換樂:小芳之戀(3) | |
| 2015: | 雪山下的絳珠草:鳳凰男的奮鬥(4) | |



























